Mar 16, 2026 · 32m · tbpn
AI vs. Dog Cancer, Timothée Chalamet Under Fire, ‘Agents Over Bubbles' | Diet TBPN
0:00 / 0:00
▶ Watch on YouTube →
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of Diet TBPN, co-hosts Jon Ma and Jordi Hays analyze breakthroughs in AI-assisted biotechnology, the economic drivers behind massive AI infrastructure expenditures, and key shifts in tech culture and venture building.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 34.2% of the talking time here. How this is scored →
The hosts as informed peer 4.7 Guest teaching 2.7 Guest disagreement 1.2 The hosts pushing back 1.2
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Sharpest disagreement ▶ 19:25 Surfing culture ribbing
Jon playfully challenges Jordi on how people carry surfboards, prompting Jordi to distinguish between casual pretenders and genuine surfers.
Hardest push from the hosts ▶ 32:18 Clarifying Hollywood market comparisonJordi steps in to correct Jon's comparison between the video game industry and the film industry, questioning whether Jon meant theatrical box office specifically.
Biggest teaching moment ▶ 16:20 Neoantigen and target validation mechanicsJon details the exact molecular biology workflow behind neoantigen vaccine synthesis, explaining somatic mutations, peptide recognition, and AlphaFold's role.
The host holds their own ▶ 8:04 Strategic messaging reframe for AI biotechJordi articulates a comprehensive framework arguing that AI must be messaged as an empowering research assistant for humans rather than an autonomous miracle cure.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Reflections on Travis Kalanick and the Builder Mindset | 5 | 1 | 1 | 1 | Jordi Hays and Jon Ma discuss Travis Kalanick's advice on capital constraints and aggressive fundraising dynamics in the AI boom. The discussion is collaborative with mutual agreement on market scaling. | |
| AI vs Dog Cancer: The Rosie Case Study and Online Debate | 6 | 3 | 1 | 1 | Jon details the story of Paul Cunningham creating a custom mRNA vaccine for his dog using ChatGPT. Jordi contributes insights on canine testing platforms and personal perspective on clinical trial hurdles. | |
| Producer Tyler's Weekend Trip and Tech Banter | 2 | 2 | 0 | 0 | Brief small talk with producer Tyler regarding his weekend trip to San Francisco leads directly into reviewing Jensen Huang's keynote speech at Nvidia GTC. | |
| Domesticating Biotechnology: Freeman Dyson's Vision and AI Pipelines | 4 | 5 | 1 | 1 | Jon provides detailed scientific background on personalized neoantigen vaccine pipelines and target validation via AlphaFold. Jordi adds light banter and critiques the incentives in the biomedical industry. | |
| The Ultrawide MacBook Dream and Hardware Banter | 6 | 3 | 2 | 2 | The co-hosts read and debate Ben Thompson's thesis on AI compute inflection points, CapEx spending, and the MacBook Neo's market positioning. | |
| Nebius Meta AI Deal and Major Tech Restructuring | 5 | 2 | 2 | 2 | Jordi and Jon analyze the $27B Nebius-Meta infrastructure deal and discuss the cultural backlash over Timothée Chalamet's comments on opera and ballet. |
Statements from this episode (12)
Hays: A 'Travis-Sized Hole' Existed in Tech Culture After Kalanick Left
“I think that the Travis Kalanick mindset has been missing totally when he kind of left. There was, there's been a Travis sized hole in the industry, in the culture.”
Hays: Early Teams With No Product Can Raise Up to $1 Billion
“Right now a lot of easy money everywhere, right? There's teams that have built nothing that can raise between 50 to a billion dollars at times.”
Hays: AI industry should message human-AI collaboration over autonomous cures
“I think it would be helpful for the industry to refocus some messaging on not AI is going to cure cancer, but human humanity is going to use AI to cure cancer and do a number of other things. Right. And so the bar is not just like one shotting it with a prompt…”
Hays: Regulatory frustration will drive more patients to pursue DIY biotech
“That level of frustration will eventually drive more individuals, I think to do this. Right. And so there's definitely, definitely some like safety, there's huge safety concerns. There's ethical concerns. There's, these are things that we have to work through,…”
Jon Ma: Lack of target validation is top reason for drug failure
“Since the hardest part of drug discovery, whether in humans or dogs, is target validation, the lack of which leads to a lack of efficacy. The number one reason for drug failure.”
Jon Ma: AI enabled single individual to assemble biotech workflow
“Instead of requiring multiple experts, a motivated individual was able to assemble the workflow with AI acting as a kind of guide through the technical landscape.”
Dylan Patel: GPT-5.4 TAM Exceeds $100B, Meets Microsoft-OpenAI AGI Clause
“Dylan Patel said on Dorkesh, the TAM for GPC 5.4 is north of a hundred billion dollars, but there's adoption lag. That's considered AGI as far as the Microsoft OpenAI contract is concerned.”
Carter: OpenAI IP Access Now Requires Expert Review, Not Just Profit
“Sam Carter says the reported one billion of profit is no longer the sole trigger for confidential IP research access. It reportedly includes an independent expert review.”
Ma: PC makers should fear Apple's $599 MacBook Neo
“The point about the MacBook Neo is that at five 99, a lot of PC makers should be sort of quaking in their boots because you're selling at that price point.”
Ma: Nebius and Meta Agree to $27B AI Infrastructure Deal
“Nebius and Meta have agreed to a twenty seven billion dollar AI infrastructure pact, a deal. The talks are advanced to packed stage. A five-year deal, twenty-seven billion to supply AI infrastructure capacity to Meta.”
Hays: Reuters Reports Meta Planning Layoffs of 20% or More
“Meta is planning sweeping layoffs that could affect 20% or more of the company. Three sources familiar with the matter told Reuters, as Meta seeks to offset AI infrastructure bets and prepare for greater efficiency brought by AI assisted workers.”